A New Era For Alzheimer's Disease May Be Around The Corner [Forbes]
Prothena Corporation plc - Ordinary Shares (PRTA)
Last prothena corporation plc - ordinary shares earnings: 2/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.prothena.com
Company Research
Source: Forbes
AFP PHOTO / SEBASTIEN BOZON (Photo credit should read SEBASTIEN BOZON/AFP via Getty Images) The recent FDA approval of Eli Lilly's new immunotherapy for slowing the cognitive decline of early Alzheimer's marked another step forward in the push to develop effective therapies for this notoriously difficult disease. After two decades of no new Alzheimer's drugs, the FDA has approved both this new drug, , and another immunotherapy called in the past couple of years, offering the first glimmers of hope to the who live with the disease. (In Europe, where I live, that number is estimated to be nearly Both therapies attempt to clear toxic amyloid proteins from the brain through injectable monoclonal antibodies that are administered via regular infusions. Lecanemab is the most intensive, needing infusions every two weeks, while donanemab infusions are required monthly. Dr Howard Fillit, co-founder and chief science officer of the Alzheimer's Drug Discovery Foundation (ADDF) described t
Show less
Read more
Impact Snapshot
Event Time:
PRTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRTA alerts
High impacting Prothena Corporation plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PRTA
News
- ATHA Stock Tanks as Alzheimer's Study Fails to Meet Primary Goal [Yahoo! Finance]Yahoo! Finance
- Prothena to Participate in Upcoming Healthcare ConferencesBusiness Wire
- What Makes Prothena (PRTA) a New Buy Stock [Yahoo! Finance]Yahoo! Finance
- Prothena Corporation plc (PTRA): Positioning Among Top Debt-Free Stocks [Yahoo! Finance]Yahoo! Finance
- Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $66.00 to $62.00. They now have an "outperform" rating on the stock.MarketBeat
PRTA
Earnings
- 8/8/24 - Beat
PRTA
Sec Filings
- 8/8/24 - Form S-8
- 8/8/24 - Form 10-Q
- 8/8/24 - Form 8-K
- PRTA's page on the SEC website